U.K.' s NICE To Evaluate Efficacy of Bristol's Taxol In Ovarian Cancer
Executive Summary
The U.K.' s National Institute of Clinical Excellence plans an assessment of ovarian cancer therapies with Bristol-Myers Squibb's Taxol (paclitaxel) as one of its first priorities, the Department of Health announced Aug. 6.